The role of viral and bacterial infections in the pathogenesis of IPF: a systematic review and meta-analysis
- PMID: 33579274
- PMCID: PMC7880524
- DOI: 10.1186/s12931-021-01650-x
The role of viral and bacterial infections in the pathogenesis of IPF: a systematic review and meta-analysis
Abstract
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease. Several risk factors such as smoking, air pollution, inhaled toxins, high body mass index and infectious agents are involved in the pathogenesis of IPF. In the present study, this meta-analysis study investigates the prevalence of viral and bacterial infections in the IPF patients and any possible association between these infections with pathogenesis of IPF.
Methods: The authors carried out this systematic literature review from different reliable databases such as PubMed, ISI Web of Science, Scopus and Google Scholar to December 2020.Keywords used were the following "Idiopathic pulmonary fibrosis", "Infection", "Bacterial Infection" and "Viral Infection", alone or combined together with the Boolean operators "OR", "AND" and "NOT" in the Title/Abstract/Keywords field. Pooled proportion and its 95% CI were used to assess the prevalence of viral and bacterial infections in the IPF patients.
Results: In this systematic review and meta-analyses, 32 studies were selected based on the exclusion/inclusion criteria. Geographical distribution of included studies was: eight studies in American people, 8; in European people, 15 in Asians, and one in Africans. The pooled prevalence for viral and bacterial infections w ere 53.72% (95% CI 38.1-69.1%) and 31.21% (95% CI 19.9-43.7%), respectively. The highest and lowest prevalence of viral infections was HSV (77.7% 95% CI 38.48-99.32%), EBV (72.02%, 95% CI 44.65-90.79%) and Influenza A (7.3%, 95% CI 2.66-42.45%), respectively. Whereas the highest and lowest prevalence in bacterial infections were related to Streptococcus sp. (99.49%, 95% CI 96.44-99.9%) and Raoultella (1.2%, 95% CI 0.2-3.08%), respectively.
Conclusions: The results of this review were confirmed that the presence of viral and bacterial infections are the risk factors in the pathogenesis of IPF. In further analyses, which have never been shown in the previous studies, we revealed the geographic variations in the association strengths and emphasized other methodological parameters (e.g., detection method). Also, our study supports the hypothesis that respiratory infection could play a key role in the pathogenesis of IP.
Keywords: Bacterial infection; Epidemiology; Idiopathic pulmonary fibrosis; Meta-analysis; Viral infection.
Conflict of interest statement
The authors declare that they have no conflicting interests.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7881540/bin/12931_2021_1650_Fig1_HTML.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7881540/bin/12931_2021_1650_Fig2_HTML.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7881540/bin/12931_2021_1650_Fig3_HTML.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7881540/bin/12931_2021_1650_Fig4_HTML.gif)
![Fig. 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7881540/bin/12931_2021_1650_Fig5_HTML.gif)
![Fig. 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7881540/bin/12931_2021_1650_Fig6_HTML.gif)
Similar articles
-
Bacterial and viral coinfection in idiopathic pulmonary fibrosis patients: the prevalence and possible role in disease progression.BMC Pulm Med. 2022 Feb 11;22(1):60. doi: 10.1186/s12890-022-01853-y. BMC Pulm Med. 2022. PMID: 35148733 Free PMC article.
-
Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis: A Meta-Analysis.Chest. 2020 May;157(5):1175-1187. doi: 10.1016/j.chest.2019.10.032. Epub 2019 Nov 12. Chest. 2020. PMID: 31730835 Free PMC article.
-
Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.Clin Respir J. 2018 Mar;12(3):1084-1092. doi: 10.1111/crj.12631. Epub 2017 Apr 12. Clin Respir J. 2018. PMID: 28332341 Review.
-
The role of infection in the pathogenesis of idiopathic pulmonary fibrosis.Eur Respir Rev. 2013 Sep 1;22(129):376-81. doi: 10.1183/09059180.00000713. Eur Respir Rev. 2013. PMID: 23997064 Free PMC article. Review.
-
Lung cancer in idiopathic pulmonary fibrosis: A systematic review and meta-analysis.PLoS One. 2018 Aug 16;13(8):e0202360. doi: 10.1371/journal.pone.0202360. eCollection 2018. PLoS One. 2018. PMID: 30114238 Free PMC article.
Cited by
-
Platelet Activating Factor Receptor and Intercellular Adhesion Molecule-1 Expression Increases in the Small Airway Epithelium and Parenchyma of Patients with Idiopathic Pulmonary Fibrosis: Implications for Microbial Pathogenesis.J Clin Med. 2024 Apr 6;13(7):2126. doi: 10.3390/jcm13072126. J Clin Med. 2024. PMID: 38610892 Free PMC article.
-
The Impact of Occupational Exposures on the Risk of Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.Ann Am Thorac Soc. 2024 Mar;21(3):486-498. doi: 10.1513/AnnalsATS.202305-402OC. Ann Am Thorac Soc. 2024. PMID: 38096107
-
Mendelian randomization reveals no correlations between herpesvirus infection and idiopathic pulmonary fibrosis.PLoS One. 2023 Nov 28;18(11):e0295082. doi: 10.1371/journal.pone.0295082. eCollection 2023. PLoS One. 2023. PMID: 38015883 Free PMC article.
-
In vitro co-culture studies and the crucial role of fibroblast-immune cell crosstalk in IPF pathogenesis.Respir Res. 2023 Nov 27;24(1):298. doi: 10.1186/s12931-023-02608-x. Respir Res. 2023. PMID: 38012580 Free PMC article. Review.
-
Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies.Front Pharmacol. 2023 Aug 7;14:1205948. doi: 10.3389/fphar.2023.1205948. eCollection 2023. Front Pharmacol. 2023. PMID: 37608885 Free PMC article. Review.
References
-
- Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier J-F, Flaherty KR, Lasky JA. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824. doi: 10.1164/rccm.2009-040GL. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical